Carfilzomib (Kyprolis) in combination with melphalan and prednisone for multiple myeloma – first line
NIHR HSRIC
Record ID 32016001000
English
Authors' objectives:
Carfilzomib is a new drug to treat multiple myeloma that is delivered straight into the blood stream via a drip. It is given alongside drugs already used to treat multiple myeloma and it may increase survival in some patients with this disease.
Details
Project Status:
Completed
URL for project:
http://www.hsric.nihr.ac.uk/topics/carfilzomib-kyprolis-in-combination-with-melphalan-and-prednisone-for-multiple-myeloma/
Year Published:
2016
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Antineoplastic Combined Chemotherapy Protocols
- Humans
- Melphalan
- Multiple Myeloma
- Oligopeptides
- Prednisone
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.